1Iwatani W , Arika T , Yamaguchi H. Twomechanisms of butenafine action in Candidaalbicans. Antimicrob Agents Chemother1993 ;37 :785 - 788.
2Minggeot-Leclercq MP, Callet X, Flore C, et al. Experimental and conformational analyses of interactions between butenafine and lipids[J]. Antimicrob Agents Chemother,2001, 45(12): 3347-3354.
3Nimura K, Niwano Y, Ishiduka S, et al. Comparison of in vitro antifwngal activities of topical antinycotics launched, in 1990s in Japan[J].Int J Antimicrob Agents, 2001, 18(2): 173-178.
4MINGEOT-LECLERCQ M P,GALLET X,FLORE C,et al.Experimental and conformational analyses of interactions between butenafine and lipids[J].Antimicrob Agents Chemother,2001,45(12):3347-3354.
5Naha WH,Orengo I,Rosen T.The antifungal agent butenafine manifests anti-inflammatory activity in vivo.J Am Acad Dermatol 1999;41:203-206.
6Tschen E,Elewski B,Gorsulowsky DC,et al.Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.J Am Acad Dermato1 1997;36:9-14.
